CHIPPING CAMPDEN SURGERY
BACK ENDS, CHIPPING CAMPDENAF006
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 3 years (excluding those patients with a previous CHADS2 or CHA2DS2-VASc score of 2 or more)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
AF 5 | 2013 | 88 | 93 | 94.6% | |
AF002 | 2014 | 80 | 80 | 100.0% | |
AF006 | 2016 | 150 | 154 | 97.4% | |
AF006 | 2017 | 71 | 71 | 100.0% | |
AF006 | 2018 | 128 | 128 | 100.0% | |
AF006 | 2019 | 74 | 80 | 92.5% | |
AF006 | 2020 | 88 | 96 | 91.7% | |
AF006 | 2021 | 58 | 83 | 69.9% | |
AF006 | 2022 | 52 | 72 | 72.2% | |
AF006 | 2023 | 97 | 98 | 99.0% |